Michael Burgess

It is time for Congress to finally pass this commonsense legislation.

I do appreciate the administration's commitment to healthcare.

I am simply suggesting it is an important issue that we need to take up.

Ironically, this bill is called the Women's Health Protection Act of 2019, even though, if this bill became law, it would put women's health and safety at risk.

The bill is called the Women's Health Protection Act of 2019, even though if this bill became law, it would put women's health and safety at risk.

My dedication to pro-life medicine remains steadfast.

The question of abortion, sometimes reduced to yet another political issue, is personal for some of us.

I do feel that today's hearing is an indication of where the Democratic Party is headed.

My belief in the right to life has influenced my professional career for much longer than my time in Congress.

This bill transcends pro-life and pro-choice.

I am a physician. Most members of Congress are not.

As the viability of a baby occurs earlier with the help of medical innovation, the Roe v. Wade standard inherently extends the rights of states to regulate earlier in a pregnancy term.

Not only does the bill raise questions about the Democrats' concern for women's health and safety, it also raises questions about the regard for the United States Constitution.

I think the support of this bill is an enormous opportunity.

Counterfeit devices pose a risk to Americans.

The Food and Drug Administration is the oldest comprehensive consumer protection agency within the Federal Government.

And I thank the Chair. And welcome to our witnesses, welcome to the witnesses of both panels in fact, because we do have a great deal in front of us this morning.

May I inquire of the gentleman from California (Mr. DeSaulnier) how many more speakers he has. Mr. DeSAULNIER. Mr. Speaker, I have one more speaker.

It was clearly a very tragic situation, young high school athlete who got hit. So it was a high-profile case in the community and something I will never forget.

So you can't really quantitate to the degree of behavioral disruption that may occur.

I hope that we will get an update on the administrative efforts to streamline the research process today.

So is marijuana a gateway drug? Some people call it that. Is that a fair statement?

Some of the bills before us are a step in the right direction. Some go a step too far.

I appreciate that we are holding this hearing today to discuss marijuana policy, a topic that is of interest to many Members.

Thank you, Madam Chair. Last Congress, the Energy and Commerce Committee worked in a bipartisan manner to produce legislation that was signed into law by President Trump.